Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.33x is 33% above its 3-year average of -0.49x, around the middle of its 3-year range (-41.50x–45.14x).
1219.51% below its 12-month average of 0.03x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 0.77x.
INTEREST COVERAGE RATIO
-0.33x
INTEREST COVERAGE RATIO AVG TTM
0.03x
INTEREST COVERAGE RATIO AVG 3Y
-0.49x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1219.51%
CURRENT VS 3Y AVG
+33.07%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.72x
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-104.91%
vs the sector median at left
Fortrea Holdings Inc.
Market Cap
$1.90B
Interest Coverage Ratio
-0.33x
TTM Avg
0.03x
3Y Avg
-0.49x
5Y Avg
N/A
Market Cap
$1.74B
Interest Coverage Ratio
2.86x
TTM Avg
2.86x
3Y Avg
2.86x
5Y Avg
6.42x
Market Cap
$1.71B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.16B
Interest Coverage Ratio
-358.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.52B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.76B
Interest Coverage Ratio
7.88x
TTM Avg
5.24x
3Y Avg
5.24x
5Y Avg
5.24x
Market Cap
$1.00B
Interest Coverage Ratio
-13.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$474.59M
Interest Coverage Ratio
-17.61x
TTM Avg
2.56x
3Y Avg
1.47x
5Y Avg
1.63x
Market Cap
$458.62M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | $1.90B | -0.33x | 0.03x | -0.49x | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 2.86x | 2.86x | 2.86x | 6.42x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | N/A | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -358.08x | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -8.77x | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 7.88x | 5.24x | 5.24x | 5.24x |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -13.34x | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | -17.61x | 2.56x | 1.47x | 1.63x |
| NRC Health (NRC)vs › | $458.62M | 4.74x | 9.15x | 25.82x | 26.16x |
| Shoulder Innovations, Inc. (SI)vs › | $394.23M | -375.67x | N/A | N/A | N/A |
Interest Coverage
-0.3x
Debt/Equity
2.13
Current Ratio
0.96
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.77x |
| 2026-03-31 | 0.17x |
| 2025-12-31 | 0.38x |
| 2025-09-30 | -0.70x |
| 2025-06-30 | -0.47x |
| 2025-03-31 | -23.32x |
| 2024-12-31 | -2.54x |
| 2024-09-30 | -0.80x |
| 2024-06-30 | -1.13x |
| 2024-03-31 | -1.09x |
| 2023-12-31 | -0.31x |
| 2023-09-30 | 0.30x |
| 2023-06-30 | 45.14x |
| 2022-12-31 | -41.50x |
